-+ 0.00%
-+ 0.00%
-+ 0.00%
JCR Pharma (4552) 2Q operating loss turned to deficit (▲3.504 billion yen for April-September consolidated), forecasted 1.1 billion yen for March 2027
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending